Full explanation of the drug registration procedure and regulations governing the process
(1888PressRelease) August 27, 2008 - Today, URCH Publishing Ltd announces the publication of a major new reference report covering the regulation of licensing medicines in China.
Drug Registration in China: A comprehensive overview of procedures provides in-depth detail on the revised Drug Registration Procedure which came in to into effect on 1 October 2007.
Authored by Laing Kong, a graduate of the prestigious China Pharmaceutical University, the 148 page report clearly and comprehensibly provides a detailed overview of the procedures necessary to register a medicine in the Chinese market.
Edwin Bailey, managing director of URCH Publishing commenting on the report’s publication said: “The publication of this report is timely bearing in mind last year’s major change to pharmaceutical regulation in China and the rapid growth of the local pharmaceutical market”.
The 51,000 word report contains a full explanation of the drug registration procedure and regulations governing the process, including:
• An outline of the major responsibilities the State Food and Drug Administration (SDFA)
• In-depth analysis of the regulations surrounding the drug registration for imported drugs.
• Comprehensive detail on applications for biologics, Chinese medicines, generics, imported medicines, OTCs, and supplementary products.
• Summary of requirements for the application material for Traditional Chinese Medicines and natural drugs
More information about Drug Registration in China: A comprehensive overview of procedures priced at £495 can be found at:
http://www.urchpublishing.com/publications/regulatory/drug_registration_china
About URCH Publishing Ltd
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. The company is based in London, UK. For more information contact URCH Publishing on +44 (0) 20 7060 1099 or email press[a]urchpublishing.com.